Douglas E. Williams

This profile gathers the share dealings of Douglas E. Williams across 3 companies, led by Codiak BioSciences, Inc., Ironwood Pharmaceuticals Inc and Ovid Therapeutics Inc. Over a trading history stretching from 1 June 2016 to 28 March 2023, the count stands at 13 filings.

On the open market, the record shows 1 purchase worth €29k and 4 sales worth €29k. Taken together, the sales exceed the purchases by €737. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants and 3 option exercises. Since January 2023: no purchases and 4 sales on the market.

The latest filing, published on 30 March 2023, reports an open-market sale of €6,919 in Codiak BioSciences, Inc. The last purchase on record was published on 16 August 2018, which is 2,990 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.